Green Cross Cell Corporation (031390.KQ)

Green Cross Cell Corporation (031390.KQ) — VMCI valuation read

031390.KQ screens at VMCI 51/100, a 1-point gap above the Healthcare sector median (50). For a mid-cap Green Cross Cell Corporation share, that placement says the multi-pillar composite is cheaper or higher quality than the typical peer on a like-for-like basis.

031390.KQ has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 031390.KQ trades at 22.0x earnings, 22% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp, the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 2.5x is the rate-sensitivity line to watch, which sets the rate-cycle exposure for Green Cross Cell Corporation.

031390.KQ rose 2.5% over the trailing 7 days, with a +2.3% read on a 30-day basis.